Nanophase Technologies Corporation
NANX
$2.51
$0.187.73%
| Weiss Ratings | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.44 | |||
| Price History | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.06% | |||
| 30-Day Total Return | -10.12% | |||
| 60-Day Total Return | -8.06% | |||
| 90-Day Total Return | 63.52% | |||
| Year to Date Total Return | 7.73% | |||
| 1-Year Total Return | 402.00% | |||
| 2-Year Total Return | 43.43% | |||
| 3-Year Total Return | -22.77% | |||
| 5-Year Total Return | 660.61% | |||
| 52-Week High % Change | -26.03% | |||
| 52-Week Low % Change | 482.50% | |||
| Price | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.15 | |||
| 52-Week Low Price | $0.40 | |||
| 52-Week Low Price (Date) | Mar 07, 2024 | |||
| 52-Week High Price (Date) | Jan 27, 2025 | |||
| Valuation | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 163.13M | |||
| Enterprise Value | 176.84M | |||
| Price/Earnings (TTM) | 96.68 | |||
| Earnings Per Share (TTM) | 0.02 | |||
| Earnings Per Share Growth | -127.70% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.51 | |||
| Price/Book (Q) | 10.74 | |||
| Enterprise Value/Revenue (TTM) | 3.70 | |||
| Price | $2.51 | |||
| Enterprise Value/EBITDA (TTM) | 40.40 | |||
| Enterprise Value/EBIT | 51.12 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 71.94M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 630 771 6708 | |||
| Address | 1319 Marquette Drive Romeoville, IL 60446 | |||
| Website | www.nanophase.com | |||
| Country | United States | |||
| Year Founded | 1989 | |||
| Profitability | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.23% | |||
| Profit Margin | 5.57% | |||
| Management Effectiveness | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.38% | |||
| Return on Equity | 27.92% | |||
| Income Statement | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 47.20M | |||
| Total Revenue (TTM) | 47.79M | |||
| Revenue Per Share | $0.66 | |||
| Gross Profit (TTM) | 13.89M | |||
| EBITDA (TTM) | 4.38M | |||
| EBIT (TTM) | 3.46M | |||
| Net Income (TTM) | 2.67M | |||
| Net Income Avl. to Common (TTM) | 2.67M | |||
| Total Revenue Growth (Q YOY) | 111.94% | |||
| Earnings Growth (Q YOY) | 312.05% | |||
| EPS Diluted (TTM) | 0.02 | |||
| EPS Diluted Growth (Q YOY) | 233.33% | |||
| Balance Sheet | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.93M | |||
| Cash Per Share (Q) | $0.04 | |||
| Total Current Assets (Q) | 29.76M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 15.17M | |||
| Current Ratio (Q) | 1.278 | |||
| Book Value Per Share (Q) | $0.22 | |||
| Total Assets (Q) | 48.05M | |||
| Total Current Liabilities (Q) | 23.29M | |||
| Total Debt (Q) | 16.64M | |||
| Total Liabilities (Q) | 32.88M | |||
| Total Common Equity (Q) | 15.17M | |||
| Cash Flow | NANX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.16M | |||
| Cash from Financing (TTM) | 6.77M | |||
| Net Change in Cash (TTM) | 1.74M | |||
| Levered Free Cash Flow (TTM) | -5.73M | |||
| Cash from Operations (TTM) | -2.87M | |||
